Huntington is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion

Nature Genetics

Volumn 17, Issue 4, 1997, Pages 404-410

  White, Jacqueline K ^a   Auerbach, Wojtek ^b   Duyao, Mabel P ^a   Vonsattel, Jean Paul ^a   Gusella, James F ^a   Joyner, Alexandra L ^b   MacDonald, Marcy E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; HUNTINGTIN; HD PROTEIN, HUMAN; HDH PROTEIN, MOUSE; NERVE PROTEIN; NUCLEAR PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; DEGENERATIVE DISEASE; GENE EXPRESSION; GENE MUTATION; HOMOZYGOSITY; HUNTINGTON CHOREA; LETHALITY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERINATAL MORTALITY; PRIORITY JOURNAL; ALLELE; ANIMAL; CELL DIFFERENTIATION; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; METABOLISM; MOUSE MUTANT; NUCLEOTIDE REPEAT; PATHOLOGY; PHENOTYPE; PRENATAL DEVELOPMENT; TRANSGENIC MOUSE;

ANIMALIA;

ALLELES; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC AND FETAL DEVELOPMENT; GENE DELETION; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HUNTINGTON DISEASE; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUTAGENESIS, INSERTIONAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0030613177     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1297-404     Document Type: Article

References (15)

1. Martin, J.B. & Gusella, J.F. Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315, 1267-1276 (1986).
2. Vonsattel, J.P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577 (1985).
3. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983 (1993).
4. McNeil, S.M. et al. Reduced penetrance of the Huntington's disease mutation. Hum. Mol. Genet. 6, 775-779 (1997).
5. Rubinsztein, D.C. et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet. 59, 16-22 (1996).
6. Gusella, J.F., Persichetti, F. & MacDonald, M.E. The genetic defect causing Huntington's disease: repeated in other contexts? Mol. Med. 3, 238-246 (1997).
7. Ide, K. et al. Abnormal gene product identified in Huntington's disease lymphocytes and brain. Biochem. Biophys. Res. Commun. 209, 1119-1125 (1995).
8. Trottier, Y. et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10, 104-110 (1995).
9. Jou, Y.S. & Myers, R.M. Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465-469 (1995).
10. Sharp, A.H. et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074 (1995).
11. DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081 (1995).
12. Gutekunst, C.-A. et al. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA 92, 8710-8714 (1995).
13. Persichetti, F. et al. Normal and expanded Huntington's disease alleles produce distinguishable proteins due to translation across the CAG repeat. Mol. Med. 1, 374-383 (1995).
14. Trottier, Y. et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403-406 (1995).
15. Persichetti, F. et al. Huntington's disease CAG trinucleotide repeats in neuropathologically confirmed post-mortem brains. Neurobiol. Dis. 1, 159-166 (1995).